International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Quinidine Sulfate 10 mg/mL in SyrSpend SF pH4

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2020 - Volume 24, Number 2
View All Articles in Issue

Page(s): 136

Quinidine Sulfate 10 mg/mL in SyrSpend SF pH4 Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Quinidine Sulfate 10 mg/mL in SyrSpend SF pH4. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, quinidine sulfate, formulation, stability, storage temperature, antimalarial schizonticide, amebicide, malaria, cardiac depressant, antiarrhythmic agent, heart arrhythmia

Related Categories: EXCIPIENTS, FORMULATIONS, CARDIOLOGY, INFECTIOUS DISEASE

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Quinidine Sulfate 10 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2020 Pg. 136
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Quinidine Sulfate 10-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2005 Pg. 479
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Stability of Acetazolamide, Baclofen, Dipyridamole, Mebeverine Hydrochloride, Propylthiouracil, Quinidine Sulfate, and Topiramate Oral Suspensions in SyrSpend SF PH4 de Oliveira Ferreira Anderson, Polonini Hudson, Loures da Silva Sharlene, Buzinari Aglio Natália Cristina, Abreu Jordana, Fernandes Brandão Marcos Antônio	Jul/Aug 2017 Pg. 339-346
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 412
Hydroxychloroquine Sulfate 25 mg/mL in Ora-Plus:Ora-Sweet SF Allen Loyd V Jr	Jul/Aug 2020 Pg. 316
Amiodarone Hydrochloride 5 mg/mL in SyrSpend SF pH4 Cherry Flavored Allen Loyd V Jr	Jan/Feb 2020 Pg. 54
Minocycline Hydrochloride 10 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2020 Pg. 133
Hydroxychloroquine Sulfate 25 mg/mL in Oral Mix or Oral Mix SF Allen Loyd V Jr	Nov/Dec 2017 Pg. 494
Stability of Extemporaneously Prepared Hydroxychloroquine Sulfate 25-mg/mL Suspensions in Plastic Bottles and Syringes McHenry Adam R, Wempe Michael F, Rice Peter J	May/Jun 2017 Pg. 251-254
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF Geiger Christine M, Sorenson Bridget, Whaley Paul	Sep/Oct 2015 Pg. 420-427
Acetazolamide 25 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2020 Pg. 130
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 503
Phenobarbital 10 mg/mL in SyrSpend SF pH4, Cherry Flavored Allen Loyd V Jr	Mar/Apr 2022 Pg. 146
Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored Allen Loyd V Jr	Jul/Aug 2021 Pg. 327
Valsartan 4-mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jul/Aug 2021 Pg. 329
Nitrofurantoin 2 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Mar/Apr 2020 Pg. 134
Return to Top